Latest news with #Flagship
New Straits Times
6 days ago
- Automotive
- New Straits Times
Proton officially launches X50, prices from RM89,800-RM113,300
PROTON Holdings Bhd has finally announced the prices the updated X50, several weeks after it was previewed to Malaysians. The SUV comes in three variants: X50 1.5TD Flagship at RM113,300, X50 1.5TD Premium at RM101,800 and X50 1.5TD Executive at RM89,800. However, there is a RM4,000 rebate for the first 10,000 customers as part of the national carmaker's Gempak! Deal for early bird customers who register their vehicles by Oct 31. Proton said since it first hit Malaysian roads in 2020, the X50 has completely changed expectations for its class and reset goalposts with over 140,000 units sold, making it Malaysia's best-selling B-segment SUV for five consecutive years. Developed in collaboration with Geely, the SUV is a global success story, with over 1.2 million units sold across 51 countries. The latest model introduces comprehensive upgrades inside and out, offering customers an even more refined, dynamic and intelligent driving experience. "The all-new Proton X50 reflects our continuous pursuit of excellence in automotive design and technology," said Proton chief executive officer Li Chunrong at its launch on Thursday. "Our ambition is to raise the standard for the B-segment, giving Malaysian drivers an experience that is smart, spirited, and truly next-generation, Made for Malaysia, Engineered for the World!" he added. The updated X50 ushers in a new era with a striking design evolution, enhanced ADAS Level 2, and a massive 14.6-inch infotainment display. One of its standout innovations is the world's first Bahasa Melayu voice command system, a proud local-first that brings intuitive connectivity to more Malaysians in their everyday language. Under the hood, the new 1.5TD i-GT engine paired with a seven-speed DCT delivers 133 kW and 290 Nm of torque, achieving 0-100 km/h 7.6 seconds - 0.3 seconds quicker than its predecessor. Coupled with a 4.7 per cent improvement in fuel economy, it offers a perfect balance of power and efficiency. Colour-wise, Proton has added a new option called Teal Bayou Green alongside the four existing colours namely Snow White, Passion Red, Jet Grey and Armour Silver. Interior-wise, the Executive and Premium variants are draped in black although they do have different upholstery material - fabric and leatherette respectively. The Flagship variant also has leatherette upholstery but it is draped in black and red instead.
New Straits Times
02-07-2025
- Business
- New Straits Times
Tropicana, MBSB Bank offer attractive financing for Johor's Skypark Kepler
JOHOR BHARU: Tropicana Corp Bhd has teamed up with MBSB Bank to offer an attractive financing package for Skypark Kepler, the first branded residences by Banyan Group, located within the Lido Waterfront Boulevard (Lido) development in Johor. Under the collaboration, eligible buyers can enjoy competitive financing margins from as low as 3.85 per cent and flexible loan tenures of up to 35 years. The exclusive financing solution, coupled with a special preferential rate, is tailored specifically for Skypark Kepler purchasers, said Usman Ghouse, MBSB Bank's group head of consumer banking. "We are proud to support Tropicana's Skypark Kepler with a tailored financing package, making premium homeownership more accessible to various buyers alike," said Usman. "This collaboration reflects MBSB Bank's ongoing commitment to empower aspiring homeowners through smart, flexible financial solutions." Skypark Kepler is the first phase of Lido, strategically situated within the Johor Bahru Waterfront Zone - a premium incentive area under the Flagship A Johor-Singapore Special Economic Zone. Starting from RM580,000, Skypark Kepler comprises 1,596 fully furnished designer units ranging from 463 sq ft to 807 sq ft across two elegant 54-storey towers, designed to appeal to young professionals, families and retirees alike. Tropicana managing director for marketing, sales and business development Ixora Ang shared that partially furnished units in Tower A are priced at about RM1,300 per sq ft, while the fully furnished residences in Tower B, featuring premium fittings and furnishings from brands like Samsung and Kohler, are priced at about RM1,800 per sq ft. "We conceptualised the Lido master plan years ago, envisioning it as Johor's future metropolis and our crown jewel in the Southern region. Lido will be a landmark township integrating seven key components, exceptional connectivity, and sustainable smart city living," she said. "We hosted soft launches to gauge the market response to this first, branded residences, and have received positive feedback." Tropicana executive director for marketing and sales Jenny Low said around 80 units at Skypark Kepler have been sold to date, with a gross development value of RM100 million - most purchases coming from foreign buyers. Skypark Kepler's official launch was marked by the unveiling of its new show units and an upgraded property gallery at Danga Bay. The freehold development stands out for its many unique features, including international zoning, proximity to the Johor Bahru-Singapore Rapid Transit System, unobstructed waterfront views, a 2.5km coastal boardwalk, a 32-acre green park, and a cultural centre. In November 2024, Tropicana held the official groundbreaking ceremony with main contractor China State Construction Engineering Corporation and signed partnership agreements with Banyan Group, Samsung, and Kohler for the residences' premium finishes and appliances. In May 2025, Tropicana appointed global architecture firm Skidmore, Owings and Merrill to lead the Lidomaster plan transformation. According to Dr. Jeffrey Yee, Tropicana's managing director for the southern region, Skypark Kepler is slated for completion and handover by late 2029 or early 2030.
The Independent
27-05-2025
- Business
- The Independent
American Airlines opens new lounges that are ‘like hotels', with spa-style showers and fireplaces
American Airlines has opened an 'oasis' at Philadelphia International Airport — two connected lounges one-and-a-half times as big as a hockey rink that the carrier claims feel more like hotels than airports, with spa-style showers and cozy fireplaces. The new Flagship and Admirals Club lounges, which share a reception area, are located in the A-West terminal between gates A15 and A16 and replace the Admirals Club lounge in the A-East terminal. American said in a statement that 'every element' of the lounges 'has been thoughtfully curated to balance style, comfort and function', leading to the spaces 'feeling less like an airport and more like a modern hospitality destination'. The carrier explained that passengers will be surrounded by 'natural materials, warm woods and organic textures', with 'zoned lighting and ambient music setting the tone for relaxation or focus'. Seating options include café chairs, bar stools, lounge seats and private work pods, with both lounges, which cover 25,000 square feet, organized into 'neighborhoods'. In the 'lounge neighborhood' is 'plush seating and a cozy fireplace', the 'dining and bar neighborhoods' are a mix of self-serve stations and full-service bars; the 'villas' offer restrooms and spa-style showers, and the kids' room is a 'playful space for families traveling with children'. Of the two lounges, the Flagship is more upscale. Here, customers will be greeted with a complimentary glass of Champagne, enjoy panoramic runway views, relax in a spa-style shower and enjoy dishes created by renowned local chef and James Beard Award Semifinalist Randy Rucker. At the Admirals Club lounge, 'a refreshed take on the classic lounge experience', passengers can sip specialty Don Francisco coffee and order refreshments from a full-service bar. 'We are excited to welcome our customers into American's newest preflight experience with the opening of our brand-new Flagship and Admirals Club lounges in the A-West terminal,' said Heather Garboden, American's Chief Customer Officer. 'With more than 19 million travelers passing through Philadelphia last year, our passionate team worked zealously to create a calm, comfortable sanctuary away from the terminal hustle where customers can relax, recharge and feel taken care of before their journey takes off.' American had more than 355 peak-day departures out of Philadelphia International Airport in 2024 to more than 120 destinations in 26 countries.
Miami Herald
15-05-2025
- Business
- Miami Herald
Luxury beach resort owner files for Chapter 11 bankruptcy
While conventional wisdom dictates that location is the most important factor in a successful real estate business, sometimes even the best-located companies struggle to bring in customers. In February 2025, Allegiant Travel Company (ALGT) announced that it was looking to sell its 785-room Sunseeker Resort Charlotte Harbor resort in southwestern Florida after several years of poor financial performance. While February is still the popular sun-seeking season, the resort had been operating at just 35% capacity at the time that Allegiant informed investors of its plans. The $322.8 million impairment charge to keep Sunseeker operating had resulted in a fourth-quarter net loss of $216.2 million; as of May, a buyer has still not been announced. Don't miss the move: Subscribe to TheStreet's free daily newsletter A significantly smaller company behind three luxury timeshare resorts on the Jersey Shore, Flagship Resort Development Corporation is now also asking for Chapter 11 protection in New Jersey bankruptcy court. The three resorts, Flagship Resort, Atlantic Palace and La Sammana, are all located on the Atlantic City boardwalk. The petition filed in the U.S. Bankruptcy Court for the District of New Jersey states that Flagship currently haws $50 million in assets and $100 million in debts and other liabilities. Related: Airline that filed for bankruptcy selling off parts "Given the $8.3 million owed to the owners associations, the debtor's historically reduced margins, the potential costs of defending a lengthy class action proceeding, not to mention the risk of an adverse judgment therein, the debtors were forced to seek Chapter 11 relief," Flagship Resort CFO Cherie Parks said in the declaration first reported by legal outlet ProPublica. The declaration names higher interest rates and struggles recovering from the tourism dropoff during the Covid pandemic as the reasons Flagship has no other choice but to seek bankruptcy protection. It further said that over 40% of its owners defaulted on their mortgages after rising interest rates significantly decreased their value. In 2019, 19 Flagship owners sued the company over what it claimed was deceptive advertising of the timeshares as a great investment. A New Jersey court eventually awarded $1,668,423.88 to the owners while Flagship also faced a second lawsuit in February 2023 and a class-action suit in April 2023. More on retail and bankruptcy: Airline that filed for bankruptcy selling off partsHome Depot CEO sounds the alarm on a growing problemFamous restaurant files for Chapter 11 bankruptcy "Plaintiffs claimed that, during these presentations, defendant made various misrepresentations which induced them to purchase a Flagship Timeshare Interval," wrote the appellate court that confirmed the earlier ruling. "These misrepresentations included: the timeshare interval was an investment akin to a conventional real estate interest; the value of the interval would increase over time; the timeshare interval was 'readily marketable' and that they could sell it at any time; there would be no increase in the annual maintenance fees over time; they would be able to exchange their intervals; they could book rooms at a resort whenever they wanted." Development firm AC Boardwalk Investments LLC has offered a preliminary stalking horse bid to purchase Flagship for $45.5 million while the company will also hold an auction seeking higher bidders between July 16 and 18. Lenders Banc of California and Colebrook Financial Co. have additionally entered into a debtor-in-possession financing plan to provide Flagship with approximately $5 million in funds. Related: Veteran fund manager issues dire S&P 500 warning for 2025 Copyright 2025 The Arena Group, Inc. All Rights Reserved
Business Wire
15-05-2025
- Business
- Business Wire
Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer
SAN DIEGO--(BUSINESS WIRE)-- Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the appointment of Janeen Doyle, MBA, as Chief Corporate and Business Development Officer. 'Janeen's unique blend of corporate development, strategic execution, and clinical insight makes her an ideal leader to help drive the next phase of growth at Janux,' said David Campbell, Ph.D., President and CEO of Janux. 'Her proven track record of building value through transformational partnerships and her ability to integrate business and science will be instrumental as we continue advancing our pipeline of tumor-activated therapeutics.' 'I'm thrilled to join Janux at such an exciting time as the company expands its clinical programs and continues to advance its pipeline,' said Ms. Doyle. 'The company's innovative TRACTr and TRACIr platforms and its commitment to delivering safer, more effective therapies to cancer patients present tremendous opportunities. I look forward to working with the team to shape and execute the company's corporate and business development strategy.' Ms. Doyle brings more than 24 years of broad and strategic experience spanning large pharmaceutical companies, mid-sized biotech, and high-growth venture-backed enterprises. She joins Janux from Flagship Pioneering, a life sciences-focused venture capital firm, where she served as a Senior Partner and Senior Vice President of Corporate Partnerships and Program Development. At Flagship, she was responsible for strategy and execution of collaborations between Flagship's portfolio companies and global pharmaceutical and technology partners. Prior to Flagship, Ms. Doyle spent over 15 years at Bristol Myers Squibb and Celgene in a breadth of cross-functional positions of increasing responsibility, starting in areas of medical affairs and program leadership, and most recently serving as Senior Vice President of Strategy & Business Development. In that role, she oversaw a portfolio of 300+ strategic collaborations and a broad equity investing portfolio, including serving as a board observer across investments. Her leadership encompassed partnerships from discovery through commercialization across multiple therapeutic areas. Previous to this, she held roles in clinical science and operations. Janux's TRACTr and TRACIr Pipeline Janux's first clinical candidate, JANX007, is a TRACTr that targets prostate-specific membrane antigen (PSMA) and is being investigated in a Phase 1 clinical trial in adult patients with metastatic castration-resistant prostate cancer (mCRPC). Janux's second clinical candidate, JANX008, is a TRACTr that targets epidermal growth factor receptor (EGFR) and is being studied in a Phase 1 clinical trial for the treatment of multiple solid cancers including colorectal carcinoma, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma and triple-negative breast cancer. We are also generating a number of additional TRACTr and TRACIr programs for potential future development, some of which are at development candidate stage or later. We are currently assessing priorities in our preclinical pipeline. About Janux Therapeutics Janux is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Janux's proprietary technology enabled the development of two distinct bispecific platforms: TRACTr and TRACIr. The goal of both platforms is to provide cancer patients with safe and effective therapeutics that direct and guide their immune system to eradicate tumors while minimizing safety concerns. Janux is currently developing a broad pipeline of TRACTr and TRACIr therapeutics directed at several targets to treat solid tumors. Janux has two TRACTr therapeutic candidates in clinical trials, the first targeting PSMA is in development for prostate cancer, and the second targeting EGFR is being developed for colorectal carcinoma, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma and triple-negative breast cancer. For more information, please visit and follow us on LinkedIn. Forward-Looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, Janux's ability to bring new treatments to cancer patients in need, expectations regarding the timing, scope and results of Janux's development activities, including its ongoing and planned preclinical studies and clinical trials, the timing of and plans for regulatory filings, the potential benefits of Janux's product candidates and platform technologies, and expectations regarding the use of Janux's platform technologies to generate novel product candidates and the strength of Janux's balance sheet and the adequacy of cash on hand. Factors that may cause actual results to differ materially include the risk that compounds that appear promising in early research do not demonstrate safety and/or efficacy in later preclinical studies or clinical trials, the risk that Janux may not obtain approval to market its product candidates, uncertainties associated with performing clinical trials, regulatory filings and applications, risks associated with reliance on third parties to successfully conduct clinical trials, the risks associated with reliance on outside financing to meet capital requirements, and other risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. You are urged to consider statements that include the words 'may,' 'will,' 'would,' 'could,' 'should,' 'believes,' 'estimates,' 'projects,' 'promise,' 'potential,' 'expects,' 'plans,' 'anticipates,' 'intends,' 'continues,' 'designed,' 'goal,' or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties Janux faces, please refer to Janux's periodic and other filings with the Securities and Exchange Commission, which are available at Such forward-looking statements are current only as of the date they are made, and Janux assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
